- Home
- ABT vs NVS Comparison
ABT vs NVS Comparison
Compare ABT & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABT
- NVS
- Stock Information
- Founded
- ABT 1888
- NVS 1895
- Country
- ABT United States
- NVS Switzerland
- Employees
- ABT N/A
- NVS N/A
- Industry
- ABT Medical/Dental Instruments
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- ABT Health Care
- NVS Health Care
- Exchange
- ABT Nasdaq
- NVS Nasdaq
- Market Cap
- ABT 221.0B
- NVS 230.5B
- IPO Year
- ABT N/A
- NVS 1991
- Fundamental
- Price
- ABT $128.86
- NVS $112.17
- Analyst Decision
- ABT Buy
- NVS Hold
- Analyst Count
- ABT 18
- NVS 6
- Target Price
- ABT $140.44
- NVS $123.67
- AVG Volume (30 Days)
- ABT 8.1M
- NVS 2.6M
- Earning Date
- ABT 04-16-2025
- NVS 04-29-2025
- Dividend Yield
- ABT 1.83%
- NVS 2.92%
- EPS Growth
- ABT 139.94
- NVS N/A
- EPS
- ABT 7.70
- NVS 5.87
- Revenue
- ABT $42,344,000,000.00
- NVS $51,722,000,000.00
- Revenue This Year
- ABT $6.77
- NVS $4.36
- Revenue Next Year
- ABT $7.39
- NVS $1.93
- P/E Ratio
- ABT $16.73
- NVS $19.10
- Revenue Growth
- ABT 5.00
- NVS 10.85
- 52 Week Low
- ABT $99.71
- NVS $96.06
- 52 Week High
- ABT $141.23
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- ABT 49.65
- NVS 57.67
- Support Level
- ABT $127.13
- NVS $109.51
- Resistance Level
- ABT $132.89
- NVS $111.95
- Average True Range (ATR)
- ABT 4.05
- NVS 2.51
- MACD
- ABT 0.32
- NVS 0.51
- Stochastic Oscillator
- ABT 61.29
- NVS 99.35
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.